Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years

(2017) Oksana Hamidi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Interim results.

(2017) Raya Leibowitz-Amit et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis

(2014) N.D. Niemeijer et al.   CLINICAL ENDOCRINOLOGY

131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis

(2013) L. T. van Hulsteijn et al.   CLINICAL ENDOCRINOLOGY

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

(2013) Ségolène Hescot et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics

(2012) P.-F. Plouin et al.   HORMONE AND METABOLIC RESEARCH

Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas

(2012) Montserrat Ayala-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Radioiodinated Metaiodobenzylguanidine (MIBG): Radiochemistry, Biology, and Pharmacology

(2011) Shankar Vallabhajosula et al.   SEMINARS IN NUCLEAR MEDICINE

Comparison of High-Specific-Activity Ultratrace 123/131I-MIBG and Carrier-Added 123/131I-MIBG on Efficacy, Pharmacokinetics, and Tissue Distribution

(2010) John A. Barrett et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid

(2009) R. Edward Coleman et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

(2009) Sara Gonias et al.   JOURNAL OF CLINICAL ONCOLOGY